Skip to main content

Table 10 Response, relapse, and EFS in AML patients

From: HOTAIR expression and prognostic impact in acute myeloid leukemia patients

Parameter

Patients’ group

n = 35

Response

Responders

27 (77.1%)

Non-responders

8 (22.9%)

Relapse

Non-relapsed

24 (68.6%)

relapsed

11 (31.4%)

EFS

Median (IQR)

12 (4-12)

Range

1-12

  1. n number, IQR interquartile range, EFS event free survival